MedPath

Perfluorobutane

Generic Name
Perfluorobutane
Drug Type
Small Molecule
Chemical Formula
C4F10
CAS Number
355-25-9
Unique Ingredient Identifier
SE4TWR0K2C

Overview

Perflubutane has been used in trials studying the diagnostic of Liver Mass, Liver Diseases, Liver Metastasis, Portal Hypertension, and Peripheral Artery Disease. It is a cardiovascular drug designed to enable ultrasound to compete more effectively with nuclear stress testing; currently the leading procedure for detecting coronary heart disease.

Background

Perflubutane has been used in trials studying the diagnostic of Liver Mass, Liver Diseases, Liver Metastasis, Portal Hypertension, and Peripheral Artery Disease. It is a cardiovascular drug designed to enable ultrasound to compete more effectively with nuclear stress testing; currently the leading procedure for detecting coronary heart disease.

Indication

适用于肝脏肿块病变的超声显影。

Associated Conditions

No associated conditions information available.

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

SONAZOID POWDER AND SOLVENT FOR DISPERSION FOR INJECTION 16 MICROLITRE PER VIAL
Manufacturer:GE Healthcare AS (Oslo Site), B. Braun Melsungen AG (Solvent)
Form:INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION
Strength:16 μL
Online:Yes
Approved: 2021/01/06
Approval:SIN16077P

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath